Status:
UNKNOWN
Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
Lead Sponsor:
Meir Medical Center
Conditions:
ASTHMA
ALLERGIC RHINITIS
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to prospectively examine the relation between topical corticosteroid use and hair cortisol concentration, among patients with moderate persistent asthma or allergic rhinit...
Detailed Description
Inhaled corticosteroids have proven effective in the treatment of asthma, suppressing airway inflammation and reducing bronchial hyper-responsiveness. Beneficial clinical outcomes include fewer asthma...
Eligibility Criteria
Inclusion
- Age of 18 years or older
- Diagnosis of asthma or allergic rhinitis, or both.
- Planned initiation of treatment with ICS and/or INGC at study recruitment, according to routine clinical practice
Exclusion
- Use of inhaled, systemic or topical corticosteroids at study initiation, or during the previous 6 months.
- Use of topical corticosteroid ointments or cream, or systemic corticosteroids during the study period.
- Disorders associated with disruption of HPA axis (Cushing syndrome, Addison syndrome).
- Insufficient hair for analysis
- Bleaching or use of artificial hair color.
- Pregnancy
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01839851
Start Date
May 1 2013
End Date
December 1 2014
Last Update
March 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel